Exelixis
EXEL
#1295
Rank
ยฃ13.03 B
Marketcap
ยฃ53.41
Share price
3.12%
Change (1 day)
69.52%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company